New treatment provides up to 24-hour duration of action for growing patient population. Detemir®(Insulin Detemir) will be competition for Lantus®
Read More »Diabetes In Control
Pargluva (muraglitazar) May Increase Risk of Heart Attack and Cancer
Pargluva® made by Merck and Co. Inc. and Bristol-Myers Squibb, may be delayed in coming to market by 2 years if additional safety studies are required by the FDA.
Read More »Type 2 Diabetes Linked to Prostate Cancer Survival
A history of type 2 diabetes is not associated with more aggressive prostate cancer, but it does predict worse long-term survival from the disease.
Read More »Providing Pedometers Can Increases Physical Activity by 6000 Steps A Day
That’s 3 Extra Miles a Day. Pedometers may help couch potatoes get sorely needed exercise.
Read More »Glargine Vs. Byetta
Those in the Byetta group lost about 5 pounds, whereas patients in the insulin glargine group gained about 4 pounds.
Read More »Higher Doses of Acetaminophen and Nonsteroidal Anti-inflammatories,Increases Ris
Higher Doses of Acetaminophen and Nonsteroidal Anti-inflammatories,Increases Risk of Hypertension in Women According to two prospective cohort studies, those women that used higher doses then 500ng per day of acetaminophen and similar doses of ibuprofen, ,independently increased the risk of hypertension.
Read More »FDA Broadens Liver Warning for Cymbalta
Patients With Liver Disease May Risk Further Liver Damage, Says FDA.
Read More »Beta-Blockers Are Poor Choice for Hypertension
Investigators report that beta-blockers are no better at preventing heart attacks in patients with hypertension than other agents, and are less effective at preventing strokes.
Read More »Cleansing the Bowel for Colonoscopy May Harm the Kidneys
Patients having a colonoscopy often object to the bowel prep most of all, and now it appears that there’s another good reason to dislike it.
Read More »Diabetic Men Have Low Testosterone Levels
According to the results of the study, men with type 2 diabetes should have testosterone levels measured more frequently.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.